Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
A Prospective, 8-Month, Randomized Pilot Study of TargetCool™ Cryo-Modulation and BENEV Exosome Regenerative Complex+® for Hair Density Enhancement in Adults With Non-Scarring Hair Thinning
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Recens Medical, Inc.
- Participants (registry)
- 15
- Start
- September 2025
- Primary completion
- May 2026
- Study completion
- May 2026
- Last registry update
- March 2026
- Countries
- United States
Conditions studied: Hair Diseases, Alopecia, Hair Thinning
Interventions: Scalp tattoo, Canfield HairMetrix®, TargetCool, Microneedle-facilitated lidocaine application
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.